Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

£4.5 million award for clinical research consortium to tackle the global threat of epidemic infectious diseases

8 February 2019

The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) has been awarded £4.5 million to accelerate clinical research to prevent illness and deaths from epidemic infectious diseases.

ISARIC – whose Global Support Centre is hosted by the University of Oxford – is a world-wide, grass-roots consortium of clinical research networks, working together on epidemic infections such as pandemic influenza, Ebola, Lassa fever, and plague.

Read more (University of Oxford website)

£4.5 million award for clinical research consortium to tackle the global threat of epidemic infectious diseases

Similar stories

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

Nuffield Department of Primary Care Health Sciences designated a WHO Collaborating Centre on Primary Health Care

Oxford research highlights the global challenge of iron deficiency

Tackling the global hypertension crisis

Oxford joins new West Africa consortium to accelerate climate and health solutions

Reimagining primary health care: a historical and contemporary scoping review of community-based primary health care models and innovations